# OLMEDA BIOSCIENCES LLC: CLIA-LDT Development and Clinical Validation of anAqueous Humor-Based Multiplex Assay for Uveal Melanoma Metastatic Risk Prediction

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | OLMEDA BIOSCIENCES LLC |
| Location | SAN DIEGO, CA |
| Project | CLIA-LDT Development and Clinical Validation of anAqueous Humor-Based Multiplex Assay for Uveal Melanoma Metastatic Risk Prediction |
| Project number | 2R42CA291243-02 |
| Mechanism | R42 |
| Institute | National Cancer Institute |
| Award | $1,028,948 |
| Awarded | 2026-09-08 |
| Project period | 2025-08-01 to 2028-07-31 |
| UEI | X8JYKGL1HJ91 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11312222). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.